NTHI
HealthcareNeOnc Technologies Holdings, Inc.
$9.15
+$0.27 (+3.04%)
Jan 5, 2026
Price History (1Y)
Analysis
NeOnc Technologies Holdings, Inc. is a company in the healthcare sector and biotechnology industry with a market capitalization of $219.33M. The revenue for the last four quarters totals $59,990. The company's financial health indicates significant losses, as reflected by a net income (TTM) of -$48,875,088. However, it has generated free cash flow of $785,115 and maintains a relatively low debt level at $5.08M against a cash balance of $1.51M. The current ratio is 0.19, suggesting that the company's short-term assets may not be sufficient to cover its short-term liabilities. The valuation context shows a price-to-book ratio of -15.07 and a price-to-sales ratio of 3656.16. The gross margin is 100.0%, indicating that the company does not incur significant costs related to sales. However, operating and profit margins are significantly negative at -77,706.3% and 0.0%, respectively.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trials for the treatment of glioblastoma; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration to patients with primary and secondary brain tumors. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. NeOnc Technologies Holdings, Inc. was incorporated in 2005 and is headquartered in Calabasas, California.
Visit website →Key Statistics
- Market Cap
- $219.33M
- P/E Ratio
- N/A
- 52-Week High
- $25.00
- 52-Week Low
- $3.20
- Avg Volume
- 60.10K
Company Info
- Industry
- Biotechnology
- Exchange
- NGM
- Country
- United States